Wen-Min Zhou
Overview
Explore the profile of Wen-Min Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guo Q, Zhang G, Zhou W, Lu Y, Chen X, Deng Z, et al.
MedComm (2020)
. 2024 May;
5(6):e547.
PMID: 38764726
Cancer is a disease with molecular heterogeneity that is closely related to gene mutations and epigenetic changes. The principal histological subtype of lung cancer is non-small cell lung cancer (NSCLC)....
2.
Guo Q, Zhou W, Zhang G, Deng Z, Chen X, Sun F, et al.
Heliyon
. 2023 May;
9(5):e16158.
PMID: 37215793
Non-coding RNAs are crucial for cancer progression, among which miR-34c-3p has been demonstrated to be a tumor suppressor in non-small cell lung cancer (NSCLC). In this study, we attempt to...
3.
Zhou W, Yan Y, Guo Q, Ji H, Wang H, Xu T, et al.
J Nanobiotechnology
. 2021 Oct;
19(1):312.
PMID: 34635104
The inherent heterogeneity of individual cells in cell populations plays significant roles in disease development and progression, which is critical for disease diagnosis and treatment. Substantial evidences show that the...
4.
Yan Y, Zhou W, Wang Y, Guo Q, Zhao F, Zhu Z, et al.
Front Mol Biosci
. 2021 Aug;
8:699929.
PMID: 34368228
SARS-CoV-2 infection has become an urgent public health concern worldwide, severely affecting our society and economy due to the long incubation time and high prevalence. People spare no effort on...
5.
Zhou W, Liu B, Shavandi A, Li L, Song H, Zhang J
Front Pharmacol
. 2021 Jun;
12:690057.
PMID: 34149432
Cancer is a major global health challenge for our health system, despite the important pharmacological and therapeutic discoveries we have seen since past 5 decades. The increasing prevalence and mortality...
6.
Yan Y, Guo Q, Wang F, Adhikari R, Zhu Z, Zhang H, et al.
Front Cell Dev Biol
. 2021 Mar;
9:639233.
PMID: 33693004
Cell-free DNA (cfDNA) is easily accessible in peripheral blood and can be used as biomarkers for cancer diagnostics, prognostics, and therapeutics. The applications of cfDNA in various areas of cancer...
7.
Wu Z, Yang Y, Wang J, Zhou W, Chen J, Fu Y, et al.
Front Pharmacol
. 2021 Feb;
11:615824.
PMID: 33519482
The emergence of multidrug resistance (MDR) has been a major issue for effective cancer chemotherapy as well as targeted therapy. One prominent factor that causes MDR is the overexpression of...
8.
Guo Q, Zhang L, Liu J, Li Z, Li J, Zhou W, et al.
Nanotheranostics
. 2021 Jan;
5(1):73-89.
PMID: 33391976
Microfluidic chip is not a chip in the traditional sense. It is technologies that control fluids at the micro level. As a burgeoning biochip, microfluidic chips integrate multiple disciplines, including...
9.
Wang X, Zou L, Wu H, Fang F, Lu J, Xiao J, et al.
Zhonghua Er Ke Za Zhi
. 2011 Nov;
49(8):583-8.
PMID: 22093419
Objective: To study the clinical characteristics and effects of immunoglobulin treatment in children with the different types of Guillain-Barré syndrome (GBS). Method: Data of 108 patients hospitalized for GBS were...